On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines.
about
Purification and mechanism of human aldehyde oxidase expressed in Escherichia coliMechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and goutMechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine DehydrogenaseSuicide inactivation of xanthine oxidoreductase during reduction of inorganic nitrite to nitric oxideXanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiolMeasurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa.The mononuclear molybdenum enzymes.An in vivo ESR spin-trapping study: free radical generation in rats from formate intoxication--role of the Fenton reactionControlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndromeMolybdenum enzymes in higher organisms.Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.Spectroscopic and electronic structure studies probing covalency contributions to C-H bond activation and transition-state stabilization in xanthine oxidase.Purification and properties of a novel ferricyanide-linked xanthine dehydrogenase from Pseudomonas putida 40.Redox chemistry of molybdenum in natural waters and its involvement in biological evolutionIn vivo evidence of free radical generation in the mouse lung after exposure to Pseudomonas aeruginosa bacterium: an ESR spin-trapping investigationCo-ordinated stage-dependent enhancement of Plasmodium falciparum antioxidant enzymes and heat shock protein expression in parasites growing in oxidatively stressed or G6PD-deficient red blood cells.The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.Reversible interconversion between sulfo and desulfo xanthine oxidase in a system containing rhodanese, thiosulfate, and sulfhydryl reagent.Why do most human liver cytosol preparations lack xanthine oxidase activity?Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches?Reaction of pyranose dehydrogenase from Agaricus meleagris with its carbohydrate substrates.Infection-associated decline of cape buffalo blood catalase augments serum trypanocidal activityPreservation of complement-induced lung injury in mice with deficiency of NADPH oxidase.The trypanocidal Cape buffalo serum protein is xanthine oxidase.The role of urate and xanthine oxidase in vascular oxidative stress: future directions.The effect of ischaemia on xanthine oxidase activity in rat intestine and liver.The structure of the inhibitory complex of alloxanthine (1H-pyrazolo[3,4-d]pyrimidine-4,6-diol) with the molybdenum centre of xanthine oxidase from electron-paramagnetic-resonance spectroscopy.Turkey liver xanthine dehydrogenase: properties of the enzyme dependent on the content of functional active sitesInhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production.Xanthine oxidase-catalysed oxidation of paracetamol.Information from e.x.a.f.s. spectroscopy on the structures of different forms of molybdenum in xanthine oxidase and the catalytic mechanism of the enzyme.Studies of the ferroxidase activity of native and chemically modified xanthine oxidoreductase.The separation of functional and non-functional xanthine oxidase by affinity chromatography.Kinetic and e.p.r. studies on the inhibition of xanthine oxidase by alloxanthine (1 H-pyrazolo [3, 4-d] pyrimidine-4,6-diol).Serum concentration and urinary excretion of uric acid following piribedil (ET 495).Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.
P2860
Q24649235-245DE7D0-A024-4DC8-8B53-7FD6F31D8BBBQ27023909-186564AA-971D-4613-A224-E377CAC1D33EQ27653269-9A84EE33-74DB-4A5F-AA17-AB32A020A2DDQ28346376-6818A1CD-7598-4B20-A4B1-DBAEB772F34BQ30336517-733C7A7D-F1DD-46DB-8ADD-2D45C8C73079Q33285055-A17C8AB5-DC37-4D3D-9CDB-09918B67773AQ33579059-A6FDED92-DBF4-4146-8199-F04E0C05BA21Q33728185-35AF2B99-F49B-4D21-BD03-C1C0D81F81A3Q33840734-D93D4DDB-0022-4C7C-A4AD-8FD41C0D6FBDQ33949833-3741FEE6-6579-4DB0-89A1-24080F92DE55Q34141630-F871A802-B318-43F2-B9CD-35E61C594C8DQ34812986-B0FBB40D-4764-41BB-976F-55A44DC7AE1AQ35063758-937784E8-1530-4383-B04A-8B5C30501AEAQ35567359-27731E5A-0886-4689-B828-9410C7351E4BQ36363632-5A6B38BA-A037-414A-84DF-83F7EDD81C89Q36482981-66A4C6E2-5618-47AC-8947-74677CD32955Q36821102-E01EB5C0-F98F-4F2F-82D7-6993884ED35DQ37227733-D24D296E-450A-4BEB-8131-FD388CC2BFBDQ37506899-1510CAE3-B241-42B3-AD87-3E3C992E0CC7Q37607410-65A5B384-ACCC-470D-BAF9-27D2AB25B288Q37663383-5937D4EC-1C29-47B7-AAA4-66D19E8DDC80Q38064334-D6C24AE3-2349-4EA5-8041-4629D059224DQ38245545-6F877440-1E1A-4C7B-BEA1-7D782BBD6A12Q38297015-FCBCE015-CBAD-4DDB-8D73-9500321F67D9Q39510744-BC34E9DC-0B5C-4AEC-9C7C-96ED830B3696Q39765904-3A3832FC-0C4D-495E-9D0B-34C969EC0801Q39830964-1C77D969-CF6D-4997-9BCF-92606A918B6CQ39936328-12B01DA7-A7E9-4402-947C-ED36DBADB46AQ41162778-790A67B9-AA91-4283-B48D-6F70163B4752Q41809411-9725A6B2-5C5A-4CB7-AC8D-CE5A5965AB6AQ41863360-C5954785-9250-4870-B8E3-F80EB9B04367Q41979237-0E5151F7-1FF6-4021-A42C-37106398E120Q42127578-7997C139-91A3-4313-91E8-E84ABB0F70A2Q42836082-1640CF64-FAC9-49B6-B3CE-F9D55DDC3BFCQ42836348-1AEFC5C6-31A7-4D5D-94D5-F919BE39B2ECQ42853091-01C979EF-319C-4246-A80C-C89814C3762AQ42924912-1243BC8A-E9AA-402F-9608-656FF16AE176Q43004017-5E6FC131-DD58-43AE-A371-49C04FC5A92BQ43241766-517F4637-0C4C-4B37-9D69-D8DFF9438993Q52749977-0D48ABF7-3E05-405A-9EC5-EB9A2B5CC61A
P2860
On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines.
description
1970 nî lūn-bûn
@nan
1970 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1970 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
name
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@ast
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@en
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@nl
type
label
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@ast
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@en
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@nl
prefLabel
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@ast
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@en
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@nl
P2093
P1476
On the mechanism of inactivati ...... er pyrazolo[3,4-d]pyrimidines.
@en
P2093
P304
P407
P577
1970-06-01T00:00:00Z